Total amount raised
Latest funding date
Location
Charles Gayer is the CEO of BioCryst Pharmaceuticals, a biotech company focused on developing treatments for rare diseases. With a strong background in commercial leadership within the pharmaceutical industry, Gayer has built deep expertise in driving growth and bringing innovative therapies to patients. His appointment as President and Chief Executive Officer marks a continued commitment to BioCryst Pharmaceuticals' mission of advancing rare disease treatments.
Who is the CEO of BioCryst Pharmaceuticals?
Charles Gayer is the President and Chief Executive Officer of BioCryst Pharmaceuticals. He brings extensive commercial and leadership experience to the role, having spent years advancing the company's commercial strategy before stepping into the top executive position. Gayer holds a degree in Business Administration from Duke University - The Fuqua School of Business, providing him with a strong foundation in strategic management and organizational leadership.
At BioCryst Pharmaceuticals, Gayer has been central to the company's commercial growth and its efforts to deliver rare disease therapies to patients worldwide.
Work History
Charles Gayer's work history includes several notable positions in the pharmaceutical industry:
- BioCryst Pharmaceuticals - President and Chief Executive Officer (January 2026 to Present)
- BioCryst Pharmaceuticals, Inc. - President and Chief Commercial Officer (August 2025 to January 2026)
- BioCryst Pharmaceuticals, Inc. - Chief Commercial Officer (January 2020 to January 2026)
- Covance/Health Technology Associates - Associate (December 1993 to October 1996)
Education History
Charles Gayer earned a degree in Business Administration from Duke University - The Fuqua School of Business. This academic background equipped him with the strategic and analytical skills that have supported his career in pharmaceutical commercial leadership and his current role as CEO of BioCryst Pharmaceuticals.
When did Charles Gayer join BioCryst Pharmaceuticals?
Charles Gayer assumed the role of President and Chief Executive Officer at BioCryst Pharmaceuticals in January 2026. Prior to this appointment, he served in senior commercial leadership roles at the company, including as Chief Commercial Officer and President and Chief Commercial Officer, giving him a deep understanding of BioCryst Pharmaceuticals' business and its rare disease portfolio.
